NCT00237237View on ClinicalTrials.gov

Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

588

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Investigative Centers, Nuremberg

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY